Organized by FSBI “N.N.Blokhin RCRC”, Health Ministry of Russia. Supported by Russian Foundation for fundamental research
XIVth International Conference Haematopoiesis Immunology
“Role of bone marrow study in cancer patients”
CONFERENCE PRESIDENT – Director of “N.N.Blokhin Russian Cancer Research Center” of Russian Ministry of Health, Chief oncologist of Russia, Academician, Professor M.I.Davydov
Chairman: Professor Nikolay N. Tupitsyn
Moderator: Professor George Janossy (UK)
Suzdal, June 4-6 2017
Date: June 4, 2017
Registration – all day
18.00 Opening Ceremony
Welcoming address of Academician M.I.Davydov, President of the Conference, RF Chief Oncologist, Director of the FSBI N.N.Blokhin RCRC
19.00 – LUNCH
9.00-10.00 . General questions of haematopoiesis in oncology. Chairpersons: Professor Marina A. Frenkel, MD, PhD, DSc; Professor Birol Guvenc, President of Turkish Hematology Association, Turkey; Professor Igor K. Vorotnikov MD, PhD, Head of breast cancer surgery FSBI “N.N.Blokhin RCRC” Russian Ministry of Health; Irina Yu. Kubasova, MD, PhD, Scientific Secretary of FSBI “N.N.Blokhin RCRC” Russian Ministry of Health
9.00-9.15 Professor Nikolay N. Tupitsyn (Head of Haematopoiesis Immunology Lab. FSBI “N.N.Blokhin RCRC” ) “Role of bone marrow in diagnostics, staging, and treatment efficasy assessment in hematologic malignancies and solid tumors”
9.15-9.30 Prof. Yibin Kang, USA (Professor of molecular Biology, Department of molecular biology, Princeton University, USA; President-elect Metastasis Research Society). “Osteoblastic and endothelial niches for bone metastasis of breast cancer”.
9.30-9.45 Xiaojun Huang (Beijing University Institute of Hematology Beijing University People's Hospital, China) "Overview in Immunotherapy for malignant hematologic related disease in China"
9.45-10.00 Professor Birol Guvenc MD, PhD, President of Turkish Hematology Association, Turkey. «History of CML»
10.00-13.00 Fundamental questions of Immune therapy and transplantation in oncology
Chairpersons: Professor Z.G.Kadagidze, Professor Jean-Francois Rossi, Professor G.L.Mentkevich
10.00-10.15 George L. Mentkewich, MD, PhD, Professor, Head of chemotherapy and transplantation department Institute of Children oncology and Haematology FSBI “N.N.Blokhin RCRC”, Ministry of Health of Russian Federation “Immune Therapy in Children Oncology”
10.15-10.30 Zaira G. Kadagidze, MD, PhD, Professor, Laboratory of Clinical Immunology of Tumors FSBI “N.N.Blokhin RCRC”, Ministry of Health of Russian Federation “Cell mechanisms of tumor immune escape”
10.30-10.50 QUESTIONS, DISCUSSION COFFE BREAK
10.50-11.10. Professor Jean-Francois Rossi, MD, PhD – Department of Hematology – CHU Saint Eloi ; University of Montpellier – Faculte de Medecine, Montpellier, France. “From Allogenic transplantation to Precision Immune Therapy in oncology”
*11.10-11.25 Maria Fadeeva, Dmitry Rogachev National Research Center “Immune reconstitution after TCRα/β and CD19 depletion in haploidentical transplantation”
11.25-11.40. Grivtsova L.Yu. MD, PhD. Laboratory of haematopoiesis immunology FSBI “N.N.Blokhin RCRC” - “Hematopoetic stem cells: role in transplantation in oncology”.
11.40-12.00. E.V. Babenko, MD, Head, Dept. Of cryoconservation with Lab. haematopoietic cell control, I.P.Pavlov Saint-Petersburg Medical University, Russia, “Cytometric maintenance of haematopoietic stem cell transplantation”
14.00 – 16.00. Immune diagnosis in oncology and oncohaematology
Chairpersons: Professor Svetlana А. Lugovskaya, Paula C. Fernandez, Desire Mayer
14.00-14.20 Paula Carolina Fernandez, Dr. Med. et phil. Nat., Abteilungsleiterin FACS/Stamzell-Labor Institut fur Labormedizin Kantonsspital Aarau AG, Aarau, Switzerland. „Fundamental basis of T‑lymphocyte differentiation in immunodiagnostic“
*14.20-14.40 E.V. Naumova MD, PhD., Department of Laboratory Diagnostics, Academy of Post-Diplomic Medical Education, Moscow “Role of T-cell clonality assessment in T-cell lymphoproliferative disorder diagnosis”
14.40-15.00. Desiree Meyer, PhD L & L Application Specialist, BD Biosciences Eastern Europe, Middle East, Africa BD Biosciences, Germany, Heidelberg «8-color immunophenotyping of B cells».
15.00-15.15. U.V. Mirolubova, Saint-Petersburg, Russian Federation, “Minimal residual disease in B-CLL”.
*15.15-15.30 O.A. Yakimovich, FSBI “N.N.Blokhin RCRC” - “Role of plasma cell aberration assessment at diagnosis of multiple myeloma”
*15.30-15.45 O.A. Beznos, Laboratory of hematopoiesis immunology, FSBI “N.N.Blokhin RCRC” - “New markers in detection of minimal residual disease in B‑lineage acute lymphoblastic leukemia. Assessment of minimal residual disease during target therapy”
From 16.00 Welcome reception.
Date: June 6, 2017
9.00-10.30 Tumor-associated glycans and antiglycans: immune therpeutic approaches
Chairpersons: Professor Nikolay V.Bovin, Professor Alexander Shtil and Zoya S. Shprekh, PhD (Director of Institute of Experimental diagnostics and therapy of tumors “N.N.Blokhin RCRC”
9.00-9.20 Professor N.V. Bovin, Head of Laboratory of Carbohydrates, M.M.Shemiakin and Yu.A.Ovchinnikov Institute of Bioorganic chemistry of Russian Academy of Sciences, Moscow, “Antiglycans in cancer diagnostics and treatment”
9.20-9.40 Prof. A.Shtil (Head, Laboratory of Cell Death Mechanisms, Carcinogenesis Research Institute, FSBI N.N.Blokhin RCRC, Russian Health Ministry, Moscow) “Lipoptosis as a mechanism of cell death induced by pentameric IgM to tumor-associated glycans”
9.40-10.00 M.P. Nikulin, MD, PhD, “N.N.Blokhin RCRC” Moscow, Russian Federatian, “Tumor-associated glycans in gastric cancer: from theory to practice”
10.00-10.15 V.I. Butvilovskya Federalstate Budgetary Institute of science “V.A. Engelgardt Institute of Molecular Biology” “Possibilities of of biological microcheaps in screening of colorectal cancer”
10.15-10.30 Shilova N.V. M.M.Shemiakin and Yu.A.Ovchinnikov Institute of Bioorganic chemistry of Russian Academy of Sciences, Moscow, and limited liability company “Semiotic” “Microcheap in diagnostics, prognosis and therapy of cancer”
10.50-13.00 Section continuation
10.50-11.05 S.V.Chulkova, MD, PhD, FSBI “N.N.Blokhin RCRC”, Ministry of Health of Russian Federation Moscow, Russian Federatian, “Key role of B1-lymphcytes in antitumor immunity in gastric cancer patients”
11.05-11.20 D.A. Ryabchikov, MD, PhD, FSBI “N.N.Blokhin RCRC”, Ministry of Health of Russian Federation, Moscow, Russian Federatian, “Immunophenotype of breast cancer: interrelation with bone marrow involvement and hemopoiesis peculiarities"
Closing of the Conference
Final programme XII International Conference "Haematopoiesis Immunology"
July 3, 2015  Final programme XI International Conference "Haematopoiesis Immunology"
June 5, 2014